Several kinases, which are downstream of FLT3, collaborate with constitutively active FLT3 (FLT3-ITD or FLT3 with mutation in the kinase domain, particularly the D835 or F691 mutations), to exacerbate AML [[19], [20], [21], [22]]. This evidence concerns the gene FLT3 and acute myeloid leukemia.